Montana Molecular News
PHASE II SBIR Funding Awarded to Montana Molecular
$1.1 million investment from the National Institutes of Health advances next generation tools for drug discovery in living cells. Montana Molecular, a privately-held company developing next generation tools for drug discovery in living cells, has been...
DAG sensor and μ-opioid receptor desensitization
Early adopters of Montana Molecular’s DAG sensor at The Vollum Institute published new results in the British Journal of Pharmacology. This study made good use of our Upward DAG sensor for diacylglycerol…
DAG sensor illuminates TRPC6 Regulation
Montana Molecular’s DAG sensor helped unravel the molecular mechanisms of TRPC6 cation channel activity which could lead to new treatments for TRPC6-associated diseases that affect cardiovascular and kidney dysfunction…
Wondering about BacMam in your favorite cell type?
BacMam technology is evolving and transduction efficiencies have improved substantially since many of these pioneering papers were published. This body of work provides a summary of what has been accomplished and a starting point for assay optimization in...
Biotek and Montana Molecular Collaborate
Montana Molecular’s assays are ideal for measuring GPCR activity on Biotek’s fluorescence plate readers! In fact, we screen and optimize all of our fluorescent assays in-house on our Biotek Synergy MX. We were curious about the new …
GEN article highlights GPCR assays from Montana Molecular
Wondering what new cell based assays are available for screening in primary cells? Need to detect ligand bias? Wishing you could measure more than one second messenger with an easy multiplex assay? Tired of multistep lytic assays for cAMP? Please...
Montana Molecular DAG sensor paper exceeds 4000 views
DAG biosensors in PLoS. Montana Molecular is very proud to announce that our PLoS paper, Simultaneous Detection of Ca2+ and Diacylglycerol Signaling in Living Cells, has now been downloaded over 4000 times! We appreciate all who have taken the time...
GTC Bio Cell Based Assay Conference
Montana Molecular thanks GTC Bio for inviting us to participate at the 8th Cell Based Assay & Screening Technologies Conference this week in San Francisco. If you are planning to be there, please be sure to check out Thom Hughes' seminar,...
JBS publishes Montana Molecular’s GPCR assays
Montana Molecular is pleased to announce the publication of our live cell GPCR assays in the August 2013 edition of the Journal of Biomolecular Screening. A Multiplexed Fluorescent Assay for Independent Second-Messenger Systems: Decoding GPCR Activation in...
Montana Molecular recognized for innovation
JALA 2013 Ten Breakthroughs in Innovation. Montana Molecular was tapped last week for the quintessential A-List in the world of laboratory automation and drug discovery: The JALA 2013 Ten Breakthroughs in Innovation. The feature article from the...
